ECM-receptor interaction |
|
ITGA5 |
integrin alpha 5 |
-1.200 |
-1.280 |
0.0006 |
0.0004 |
0.0247 |
0.0134 |
|
ITGA11 |
integrin alpha-11 |
- |
-1.653 |
- |
0.0057 |
- |
0.0417 |
|
ITGA9 |
Integrin, alpha-9 |
-2.152 |
-2.799 |
0.0007 |
0.0003 |
0.0258 |
0.0124 |
|
THBS3 |
thrombospondin 3 |
-1.785 |
-1.807 |
0.0033 |
0.0027 |
0.0438 |
0.0293 |
|
THBS2 |
thrombospondin 2 |
- |
-1.261 |
- |
0.0016 |
- |
0.0233 |
|
THBS4 |
thrombospondin-4 |
- |
-2.820 |
- |
0.0071 |
- |
0.0470 |
|
SDC3 |
syndecan 3 |
-1.123 |
-2.062 |
0.0006 |
0.0001 |
0.0246 |
0.0088 |
|
COL5A3 |
collagen type V alpha 3 |
-1.781 |
-1.859 |
0.0034 |
0.0032 |
0.0441 |
0.0318 |
|
COL5A2 |
collagen type V alpha 2 |
-1.975 |
-2.354 |
0.0028 |
0.0012 |
0.0415 |
0.0208 |
|
COL5A1 |
collagen type V alpha 1 |
-2.294 |
-2.714 |
0.0001 |
0.0000 |
0.0147 |
0.0037 |
|
HSPG2 |
heparan sulfate proteoglycan 2 |
- |
-1.334 |
- |
0.0035 |
- |
0.0330 |
|
TNC |
tenascin |
-4.707 |
-4.900 |
0.0003 |
0.0003 |
0.0198 |
0.0114 |
Glycosaminoglycan biosynthesis—keratan sulfate |
|
B4GALT4 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4, transcript variant X1 |
-1.500 |
-1.910 |
0.0007 |
0.0001 |
0.0262 |
0.0088 |
|
ST3GAL1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1, transcript variant X1 |
-1.740 |
-2.160 |
0.0038 |
0.0048 |
0.0460 |
0.0385 |
|
ST3GAL1 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 1, transcript variant X2 |
- |
-3.030 |
- |
0.0046 |
- |
0.0375 |
growth factor receptors |
|
FRS3 |
fibroblast growth factor receptor substrate 3 |
- |
-1.211 |
- |
0.0035 |
- |
0.0331 |
|
FGFR1 |
fibroblast growth factor receptor 1 isoform X6 |
- |
-1.218 |
- |
0.0002 |
- |
0.0114 |